Balance Labs Inc

Balance Labs has a negative equity position of -$3.38 million and a debt-to-equity ratio of -0.16, indicating a capital structure heavily reliant on liabilities. The company's liquidity position is weak, with a current ratio of 0.11 and negative free cash flow of -$31.77 million. Despite holding $358,980 in cash and equivalents, the company's operating cash flow is negative at -$257,020, and its net debt position is -$3.38 million. Profitability metrics are severely negative, with a return on assets of -79.92% and a return on equity of 9.41%. These figures are well below the typical performance of companies in the Business Support Services industry, which usually exhibit positive returns on both assets and equity. The company's operating income is -$29.57 million, and its net income is -$31.77 million, indicating significant operational losses. Balance Labs operates as a single business segment, providing consulting services to startups and development-stage businesses. The company does not disclose geographic revenue breakdowns, but its operations are likely concentrated in the United States, as no international revenue segments are reported. The lack of geographic diversification increases exposure to local economic conditions and regulatory changes. The company's growth trajectory is unclear due to the absence of historical revenue data for trend analysis. However, the current revenue of $6,000 is extremely low for a company of its size and operational scope, suggesting either a very early-stage business or a misreporting of financials. The outlook for the current fiscal year is not provided, but the company's financial performance indicates a need for significant improvement in revenue generation and cost control. Risk factors include a high liquidity risk due to negative free cash flow and a weak current ratio. The company's debt position is also concerning, with long-term debt of $543,000 and total liabilities of $3.77 million. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the company's negative equity and high debt levels suggest a potential for future dilution if it needs to raise additional capital. Recent events include the filing of financial statements that show a significant decline in financial health. The company has not disclosed any major business developments or strategic initiatives in the latest filings. The lack of transparency in its financial reporting and operational performance raises concerns about its long-term viability.